JOVIBI Trademark
Trademark Overview
On Friday, January 27, 2023, a trademark application was filed for JOVIBI with the United States Patent and Trademark Office. The USPTO has given the JOVIBI trademark a serial number of 97771275. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, May 14, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The JOVIBI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
General Information
Serial Number | 97771275 |
Word Mark | JOVIBI |
Filing Date | Friday, January 27, 2023 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Tuesday, May 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 11, 2023 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 15, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Regeneron Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Tarrytown, NY 10591 |
Party Name | Regeneron Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Tarrytown, NY 10591 |
Trademark Events
Event Date | Event Description |
Monday, March 6, 2023 | ASSIGNED TO EXAMINER |
Tuesday, January 31, 2023 | NEW APPLICATION ENTERED |
Wednesday, February 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, March 6, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 11, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, November 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, April 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 6, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Saturday, November 18, 2023 | SOU TEAS EXTENSION RECEIVED |
Saturday, November 18, 2023 | SOU EXTENSION 1 FILED |
Saturday, November 18, 2023 | SOU EXTENSION 1 GRANTED |
Tuesday, May 14, 2024 | SOU EXTENSION 2 FILED |
Tuesday, May 14, 2024 | SOU EXTENSION 2 GRANTED |
Tuesday, May 14, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, November 19, 2024 | SOU TEAS EXTENSION RECEIVED |